TVG Announces New Approach to Choice Modeling
TVG’s exciting new approach to choice modeling offers pharma companies the ability to make decisions based on a much more comprehensive evaluation of potential product use. Traditional models have incorporated only pieces of the many influences on product design and uptake. The Unified Market SimulatorSM includes a much richer level of data, including data not previously used in decision models.
Building on proven modeling approaches, this new market simulator goes beyond standard conjoint and discrete choice to include data such as the impact of payors and patients. It also reduces the overstatement inherent in choice models to provide a truer forecast of stated shares. TVG’s Unified Market SimulatorSM provides key insights at a variety of strategic decision points: evaluating licensing opportunities, valuating pipeline products, clinical trial design, evaluating opportunities for new indications, and gauging impact of new competition.
The outcome is a much more comprehensive evaluation of products in the context of today’s pharma markets. Clients recieve a powerful, yet simple-to-use simulator which enables them to run “what-if” scenarios, test marketing strategies and evaluate competitive responses.
For more information about TVG’s Unified Market SimulatorSM, contact Ted Felix, Senior Vice President, 215-283-5337, tfelix@tvg-inc.com.
This item was posted on Thursday, April 26th, 2007 at 11:42 am and is filed under What's New.